Changing Landscapes
Les paysages de la mine, un patrimoine contesté Ce colloque organisé par le CILA (Comité d’Information et de Liaison pour l’Archéologie, l’étude et la mise en valeur du patrimoine industriel) et le
Mon compte
Pas encore inscrit ?
Les paysages de la mine, un patrimoine contesté Ce colloque organisé par le CILA (Comité d’Information et de Liaison pour l’Archéologie, l’étude et la mise en valeur du patrimoine industriel) et le
In these lectures I will first recall the basic notions and results that are needed to study minimal surfaces in the smooth setting (above all the area formula and the first variation of the
par Alessandro Giacomini, université de Brescia
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Target populations: How do we risk-stratify? Are additional biomarkers helpful? (debates)
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Study drug and background therapy (debates).
Cardiovascular Clinical Trialists (CVCT) Forum - Paris 2012 : Non-inferiority, superiority, or both? Operationalizing the FDA guidance (debates)
Ted Porter, Social sciences, History, University of California, Los Angeles (UCLA), USA
Will new compounds be able to reduce the residual risk in high risk patients when treatment targets based on new ESC guidelines have been achieved (e.g. LDL-C lesser than 70mg/dl)?
Will new compounds be able to reduce the residual risk in high risk patients when treatment targets based on new ESC guidelines have been achieved (e.g. LDL-C lesser than 70mg/dl)?
MODIGLIANI Debate Session 5 - Saturday December 1st, 2012 NOVEL DIURETIC STRATEGIES IN HEART FAILURE Chairpersons: Keld KJELDSEN, Copenhagen, DEN - Gian Paolo ROSSI, Padua, ITA Webcast: Patrick
Will new compounds be able to reduce the residual risk in high risk patients when treatment targets based on new ESC guidelines have been achieved (e.g. LDL-C lesser than 70mg/dl)?